Janus Henderson Group PLC Buys New Stake in Harrow, Inc. (NASDAQ:HROW)

Janus Henderson Group PLC purchased a new stake in Harrow, Inc. (NASDAQ:HROW) in the third quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The fund purchased 13,500 shares of the company’s stock, valued at approximately $606,000.

Several other large investors also recently bought and sold shares of HROW. First Turn Management LLC acquired a new stake in shares of Harrow during the third quarter worth about $14,683,000. Assenagon Asset Management S.A. purchased a new position in Harrow during the 3rd quarter worth approximately $8,572,000. Charles Schwab Investment Management Inc. increased its position in Harrow by 195.9% during the third quarter. Charles Schwab Investment Management Inc. now owns 251,629 shares of the company’s stock worth $11,313,000 after buying an additional 166,602 shares during the period. Braidwell LP lifted its stake in Harrow by 47.9% in the third quarter. Braidwell LP now owns 439,638 shares of the company’s stock valued at $19,766,000 after buying an additional 142,450 shares during the last quarter. Finally, Connor Clark & Lunn Investment Management Ltd. acquired a new stake in shares of Harrow in the third quarter valued at approximately $5,864,000. Institutional investors and hedge funds own 72.76% of the company’s stock.

Analyst Upgrades and Downgrades

A number of equities analysts have recently commented on the stock. Craig Hallum lifted their target price on shares of Harrow from $45.00 to $65.00 and gave the company a “buy” rating in a report on Friday, October 4th. B. Riley dropped their price objective on shares of Harrow from $73.00 to $69.00 and set a “buy” rating on the stock in a research note on Wednesday, December 4th. Finally, Lake Street Capital increased their target price on shares of Harrow from $45.00 to $55.00 and gave the stock a “buy” rating in a research note on Friday, October 4th.

Harrow Price Performance

Harrow stock opened at $35.50 on Friday. The company has a debt-to-equity ratio of 3.23, a current ratio of 1.55 and a quick ratio of 1.44. The business has a 50 day simple moving average of $46.12 and a 200-day simple moving average of $36.05. Harrow, Inc. has a 12 month low of $9.13 and a 12 month high of $59.23. The stock has a market capitalization of $1.26 billion, a PE ratio of -37.77 and a beta of 0.69.

About Harrow

Harrow, Inc operates as an ophthalmic-focused healthcare company. The company owns ImprimisRx, an ophthalmology outsourcing and pharmaceutical compounding business. The company was formerly known as Imprimis Pharmaceuticals, Inc and changed its name to Harrow Health, Inc in December 2018. Harrow Health, Inc was incorporated in 2006 and is headquartered in Nashville, Tennessee.